Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- N/A
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
- Status
- RECRUITING
- Phase
- PHASE1
Home Blood Transfusions
- Status
- RECRUITING
- Phase
- NA
Molecular Characterization of Carbapenemase-Producing Enterobacterales
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1
CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE2
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
- Status
- RECRUITING
- Phase
- PHASE4
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1